000 01567 a2200469 4500
005 20250517135447.0
264 0 _c20170612
008 201706s 0 0 eng d
022 _a1532-2939
024 7 _a10.1016/j.jhin.2016.12.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrinda, B J
245 0 0 _aUse of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
_h[electronic resource]
260 _bThe Journal of hospital infection
_cApr 2017
300 _a426-432 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcademic Medical Centers
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aClostridioides difficile
_xdrug effects
650 0 4 _aClostridium Infections
_xdrug therapy
650 0 4 _aColitis
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMinocycline
_xanalogs & derivatives
650 0 4 _aNeoplasms
_xcomplications
650 0 4 _aRetrospective Studies
650 0 4 _aTigecycline
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aPasikhova, Y
700 1 _aQuilitz, R E
700 1 _aThai, C M
700 1 _aGreene, J N
773 0 _tThe Journal of hospital infection
_gvol. 95
_gno. 4
_gp. 426-432
856 4 0 _uhttps://doi.org/10.1016/j.jhin.2016.12.018
_zAvailable from publisher's website
999 _c26843934
_d26843934